{"organizations": [], "uuid": "5fa5b6a74eba8579dc5e7ee8c25f5d075864b8a7", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180426.html", "section_title": "Archive News &amp; Video for Thursday, 26 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-guangzhou-baiyunshan-pharmaceutica/brief-guangzhou-baiyunshan-pharmaceutical-holdings-co-says-qtrly-net-profit-attributable-rmb905-2-mln-idUSFWN1S31DO", "country": "US", "domain_rank": 408, "title": "Guangzhou Baiyunshan Pharmaceutical Holdings Co Says Qtrly Net Profit Attributable RMB905.2 Mln", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.998, "site_type": "news", "published": "2018-04-26T22:37:00.000+03:00", "replies_count": 0, "uuid": "5fa5b6a74eba8579dc5e7ee8c25f5d075864b8a7"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-guangzhou-baiyunshan-pharmaceutica/brief-guangzhou-baiyunshan-pharmaceutical-holdings-co-says-qtrly-net-profit-attributable-rmb905-2-mln-idUSFWN1S31DO", "ord_in_thread": 0, "title": "Guangzhou Baiyunshan Pharmaceutical Holdings Co Says Qtrly Net Profit Attributable RMB905.2 Mln", "locations": [], "entities": {"persons": [], "locations": [{"name": "guangzhou", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "baiyunshan pharmaceutical holdings co ltd", "sentiment": "negative"}, {"name": "baiyunshan pharmaceutical holdings co", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 26 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd:\n* QTRLY INCOME FROM OPERATIONS RMB 6.91 BILLION VERSUS RMB5.29 BILLION\n* QTRLY NET PROFIT ATTRIBUTABLE TO SHAREHOLDERS RMB905.2 MILLION VERSUS RMB484.7 MILLION Source text for Eikon:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-26T22:37:00.000+03:00", "crawled": "2018-04-27T16:53:09.012+03:00", "highlightTitle": ""}